TCOF1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 3.33066907387547E-16 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
4.82459627804133E-11 |
Normal-vs-Stage2 |
1.65187999999761E-05 |
Normal-vs-Stage3 |
4.4714000280166E-09 |
Normal-vs-Stage4 |
1.64079860809352E-12 |
Stage1-vs-Stage2 |
3.498400E-01 |
Stage1-vs-Stage3 |
7.946100E-02 |
Stage1-vs-Stage4 |
2.15019999999511E-05 |
Stage2-vs-Stage3 |
6.770600E-01 |
Stage2-vs-Stage4 |
2.423800E-02 |
Stage3-vs-Stage4 |
5.031500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
2.77555756156289E-15 |
Normal-vs-AfricanAmerican |
1.63600000213648E-08 |
Normal-vs-Asian |
8.737800E-02 |
Caucasian-vs-AfricanAmerican |
5.524800E-01 |
Caucasian-vs-Asian |
4.390800E-01 |
AfricanAmerican-vs-Asian |
5.226200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.77702297321503E-12 |
Normal-vs-Female |
1.88737914186277E-15 |
Male-vs-Female |
1.911820E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
3.041400E-04 |
Normal-vs-Age(41-60Yrs) |
1.90958360235527E-14 |
Normal-vs-Age(61-80Yrs) |
4.23439061592035E-13 |
Normal-vs-Age(81-100Yrs) |
1.074380E-02 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.389600E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.872800E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.374000E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.980600E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.693600E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.209600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
4.14020000000237E-05 |
Normal-vs-Grade 2 |
1.9682000473864E-10 |
Normal-vs-Grade 3 |
2.67674771237125E-13 |
Normal-vs-Grade 4 |
1.077800071414E-10 |
Grade 1-vs-Grade 2 |
3.500200E-01 |
Grade 1-vs-Grade 3 |
8.883600E-01 |
Grade 1-vs-Grade 4 |
2.261400E-03 |
Grade 2-vs-Grade 3 |
8.992300E-02 |
Grade 2-vs-Grade 4 |
5.88819999999268E-05 |
Grade 3-vs-Grade 4 |
8.819600E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
8.26460000435958E-09 |
Normal-vs-ccB subtype |
1.08659747866113E-11 |
ccA subtype-vs-ccB subtype |
3.824200E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.47082346302341E-12 |
Normal-vs-N1 |
1.106430E-02 |
N0-vs-N1 |
9.398200E-02 |
|
|